Should I screen adult family members or caregivers for depression using a validated tool such as the PHQ‑9?

Collateral Depression Screening for Family Members and Caregivers

Yes, you should screen adult family members and caregivers for depression using the PHQ-9, particularly when they are caring for patients with serious illness such as cancer, as caregiver burden significantly increases depression risk and impacts both caregiver and patient outcomes.

Rationale for Screening

The evidence strongly supports systematic depression screening in caregivers, though the guidelines primarily address patient populations. The ASCO cancer guidelines 1, 2 emphasize screening "during times of personal transition or reappraisal such as family crisis," which directly applies to family caregivers experiencing the stress of caring for ill relatives. The U.S. Preventive Services Task Force 3, 4 recommends universal depression screening for all adults when adequate systems are in place for diagnosis, treatment, and follow-up.

Research specifically demonstrates that caregivers have elevated depression rates. A study of caregivers for adults with intellectual disabilities found that 47% reported it was "somewhat difficult" to manage daily responsibilities, 8.2% found it "very difficult," and 4.5% found it "extremely difficult" 5. This caregiver population showed significant depressive symptomatology when screened with the PHQ-9.

Recommended Screening Approach

Use the Two-Step PHQ-9 Protocol

Start with the PHQ-2 (the first two questions):

1. "Over the past 2 weeks, have you felt little interest or pleasure in doing things?" (anhedonia)
2. "Over the past 2 weeks, have you felt down, depressed, or hopeless?" (depressed mood)

Scoring approach 1, 2:

• Score 0-1: No further screening needed
• Score 2-3: Complete the remaining 7 items of the PHQ-9

Interpret Full PHQ-9 Scores

Use a cutoff of ≥8 (not the traditional ≥10) for cancer-related caregiving contexts, as this threshold has better sensitivity 2. For general adult populations, ≥10 remains the standard cutoff 6, 7, 8, 9.

Score interpretation 1, 2:

• 1-7: None/mild symptomatology - monitor, provide support resources
• 8-14: Moderate symptomatology - refer to psychology or psychiatry for diagnostic evaluation
• 15-19: Moderate to severe - refer to psychology/psychiatry for diagnosis and treatment
• 20-27: Severe - urgent referral to psychology/psychiatry

Critical Safety Assessment

Always assess for harm to self or others first 1, 2. If positive:

• Immediate referral for emergency evaluation by licensed mental health professional
• Facilitate safe environment
• One-to-one observation
• Initiate harm-reduction interventions

Identify High-Risk Caregivers

Screen more frequently if caregivers have 1, 2:

• History of prior mood disorder
• Comorbid anxiety or substance use disorders
• Other chronic illnesses (heart disease, COPD)
• Single/not partnered status
• Unemployed or low financial resources
• Lower education level (<high school)
• Poor self-perceived health status (the strongest predictor in caregiver studies 5)

Screening Timing

Screen caregivers at 1, 2:

• Initial patient diagnosis
• Start of patient treatment
• Regular intervals during patient treatment
• Patient disease progression or recurrence
• Transition to palliative care
• Times of family crisis
• When caregiver burden visibly increases

The optimal interval isn't definitively established, but a pragmatic approach includes initial screening and then clinical judgment based on risk factors and life events 4.

Important Caveats

The PHQ-9 Measures Frequency, Not Just Severity

A critical limitation: patients often conflate symptom frequency with severity when completing the PHQ-9 10. In one study, only 10.7% of patients completed it based solely on severity (as intended), while 28.6% used frequency alone and 60.7% used a combination. Clinicians typically interpret scores as severity (79.3%), creating potential misalignment. Clarify with caregivers that they should rate how often symptoms occur, not how severe they feel.

Cultural and Age Considerations

• Use culturally sensitive assessments when possible 2
• For caregivers aged ≥60, consider the Geriatric Depression Scale as an alternative 2
• Be aware that detecting depression in older adults can be more difficult 2
• Specificity may be 3-5% higher in men and 5% higher in those aged ≥60 6

Systems Requirements

Screening is only beneficial when you have 3, 4:

• Adequate systems for accurate diagnosis
• Effective treatment options available
• Appropriate follow-up mechanisms

Without these supports in place, screening may cause more harm than benefit by identifying problems you cannot address.

Treatment Pathways for Positive Screens

For moderate symptoms (PHQ-9 8-14) 1, 2:

• Referral to support services
• Structured psychosocial interventions (group-based)
• Individual psychological therapy (CBT, behavioral activation)
• Consider pharmacotherapy if appropriate

For moderate-severe/severe symptoms (PHQ-9 ≥15) 1, 2:

• Urgent referral to psychology and/or psychiatry
• Individual psychotherapy by licensed mental health professionals
• Physician-prescribed antidepressants (choice based on side effects, interactions, patient age and preference)
• Monitor regularly for adherence and adverse events

The evidence supports both psychotherapy and second-generation antidepressants as effective treatments, either alone or in combination 11, 12. For caregivers, psychosocial group interventions addressing stress reduction, coping strategies, and social support may be particularly relevant 1, 2.